These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35820683)

  • 1. Prevalence of SARS-CoV-2 infection among obstetric patients in Ottawa, Canada: a descriptive study.
    Fakhraei R; Erwin E; Alibhai KM; Murphy MSQ; Dingwall-Harvey ALJ; White RR; Dimanlig-Cruz S; LaRose R; Grattan K; Jia JJ; Liu G; Arnold C; Galipeau Y; Shir-Mohammadi K; Alton GD; Dy J; Walker MC; Fell DB; Langlois MA; El-Chaâr D
    CMAJ Open; 2022; 10(3):E643-E651. PubMed ID: 35820683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of COVID-19 IgG Antibodies in a Cohort of Municipal First Responders.
    McGuire SS; Klassen AB; Heywood J; Sztajnkrycer MD
    Prehosp Disaster Med; 2021 Apr; 36(2):131-134. PubMed ID: 33397545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psychological impact of the COVID-19 pandemic and a SARS-CoV-2 testing programme on obstetric patients and healthcare workers.
    Ross AM; Ramlawi S; Fakhraei R; Murphy MS; Ducharme R; Dingwall-Harvey AL; White RR; Ritchie K; Muldoon K; El-Chaâr D
    Womens Health (Lond); 2022; 18():17455057221103101. PubMed ID: 35686846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study.
    Science M; Bolotin S; Silverman M; Nadarajah J; Maguire B; Parekh RS; McGeer A; Schwartz KL; Alexander L; Allen U; Ariyarajah A; Castellani L; Cohn RD; Downing M; Katz K; Kazmi K; Leis JA; Liu D; Pernica JM; Schneiderman JE; Sumaida M; Campigotto A
    CMAJ Open; 2021; 9(4):E929-E939. PubMed ID: 34642255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study.
    Atkinson A; Albert A; McClymont E; Andrade J; Beach L; Bolotin S; Boucoiran I; Bullard J; Charlton C; Crane J; Dougan S; Forest JC; German GJ; Giguère Y; Girouard G; Hankins C; Krajden M; Lang A; Levett P; Minion J; Neudorf C; Poliquin V; Robinson JL; Scott H; Stein DR; Tran V; Zahariadis G; Zhou HY; Money D;
    CMAJ Open; 2023; 11(2):E305-E313. PubMed ID: 37015743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Seroprevalence in Florida Department of Health in Palm Beach County Obstetric Clinics: A Cross-Sectional Study during the First Pandemic Surge.
    Gonik CO; Alonso AM; Gonik B
    Am J Perinatol; 2023 Jun; 40(8):912-916. PubMed ID: 34758496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
    Bhatt M; Plint AC; Tang K; Malley R; Huy AP; McGahern C; Dawson J; Pelchat M; Dawson L; Varshney T; Arnold C; Galipeau Y; Austin M; Thampi N; Alnaji F; Langlois MA; Zemek RL
    CMAJ Open; 2022; 10(2):E357-E366. PubMed ID: 35414597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.
    Savirón-Cornudella R; Villalba A; Zapardiel J; Andeyro-Garcia M; Esteban LM; Pérez-López FR
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():400-404. PubMed ID: 33285496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.
    Manolea C; Capitanescu A; Borș R; Rugescu I; Bechir M; Mehedintu C; Varlas V
    Hum Reprod Open; 2021; 2021(3):hoab028. PubMed ID: 34322605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
    Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
    J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
    PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.
    Sharma KA; Singh N; Hillman S; Mathur P; Yadav K; Garg A; Dadhwal V; Bhatla N
    Int J Gynaecol Obstet; 2023 Jan; 160(1):74-78. PubMed ID: 35324007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study.
    Lewin A; De Serres G; Grégoire Y; Perreault J; Drouin M; Fournier MJ; Tremblay T; Beaudoin J; Boivin A; Goyette G; Finzi A; Bazin R; Germain M; Delage G; Renaud C
    Can J Public Health; 2022 Jun; 113(3):385-393. PubMed ID: 35380364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.